Critical Care News

One observed determinant of more resilience among French ICU professionals in the omicron wave was ICU experience during earlier waves, according to results published in American Journal of Respiratory and Critical Care Medicine.

Among patients with COVID-19 and acute respiratory failure, survival at 1 year was more likely if they received nintedanib or pirfenidone antifibrotics, according to results published in BMC Pulmonary Medicine.

Clinical outcomes after COVID-19 vaccine-related myocarditis were similar vs. myocarditis from COVID-19 infection, and events were fewer vs. conventional myocarditis, researcher reported.

Adults receiving prolonged mechanical ventilation may benefit in terms of survival with successful weaning, according to results published in Respiratory Medicine.

Among ventilated ICU patients with suspected infection, the length of antibiotic use went down after respiratory viral panel testing was adopted, according to results published in Annals of the American Thoracic Society.

During the COVID-19 pandemic, ICU clinicians who participated in virtual group discussions about death did not have significantly lower burnout at 6 months, according to results published in Annals of the American Thoracic Society.

With earlier receipt of antibiotics for sepsis, those with vs. without metastatic cancer or shock had larger reductions in 30-day mortality, according to results published in American Journal of Respiratory and Critical Care Medicine.

Mechanically ventilated adults receiving in-bed cycling plus usual physiotherapy had similar physical function after ICU discharge to those receiving only usual physiotherapy, according to results published in NEJM Evidence.

Two years after COVID-19 hospitalization, 92% of patients continued to have either non-fibrotic-like or fibrotic-like lesions on CT scans, according to results published in The Lancet Regional Health — Americas.